Internal Medicine · Bronx, NY
NPI
1285861930
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
234 East 149th Street, Lincoln Medical and Mental Health Center
Bronx, NY, 10451
Phone (718) 579-4815
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,272
61 services
Medicare patients, 2024
37
Average age 70
Drug cost, 2024
$2.8M
2,671 prescriptions
Company payments, 2025
$77
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Addi Feinstein was code 99214 (office e&m - established), 31 times for 15 patients. In total Addi Feinstein billed 61 services in 9 codes, and Medicare paid $5,272.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-10-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 31 | 15 | $72.28 | $2,241 |
| 99222 Hospital E&M - Initial | Facility | 16 | 14 | $112.25 | $1,796 |
By year: 2022 $3,970 for 55 services; 2023 $5,476 for 67 services; 2024 $5,272 for 61 services.
Medicare prescription drug claims, 2024
In 2024, the drug Addi Feinstein prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 242 prescriptions and refills. In total Addi Feinstein wrote 2,671 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 242 | 254 | 31 | $966K |
| Atorvastatin Calcium Generic | 167 | 299 | 35 | $1,508 |
| Rosuvastatin Calcium Generic | 143 | 199 | 23 | $1,085 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 113 | 115 | 14 | $385K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 113 | 117 | 24 | $3,216 |
| Amlodipine Besylate Generic | 98 | 175 | 22 | $556 |
| Tivicay Dolutegravir Sodium | 88 | 94 | 13 | $203K |
| Tamsulosin Hcl Generic | 77 | 100 | 13 | $372 |
| Prezcobix Darunavir/Cobicistat | 69 | 79 | Under 11 | $185K |
| Jardiance Empagliflozin | 65 | 77 | Under 11 | $46K |
| Metformin Hcl Generic | 61 | 109 | 15 | $3,388 |
| Lisinopril Generic | 59 | 115 | 13 | $200 |
| Gabapentin Generic | 51 | 63 | Under 11 | $307 |
| Losartan Potassium Generic | 45 | 77 | Under 11 | $354 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 39 | 39 | Under 11 | $148K |
Brand drugs: 1,153 claims; generic drugs: 1,461 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Addi Feinstein $77 ($77 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $77.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 3 | $77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.